Cargando…
Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
This prospective observational case series study included 6 eyes of 6 consecutive glaucomatous patients. Each patient underwent trabeculectomy with mitomycin C, and received a 1.25 mg of subconjunctival bevacizumab injection at completion of the trabeculectomy. Study eyes included two with neovascul...
Autores principales: | Choi, Jin Young, Choi, Jaewan, Kim, Yeon-Deok |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817825/ https://www.ncbi.nlm.nih.gov/pubmed/20157415 http://dx.doi.org/10.3341/kjo.2010.24.1.47 |
Ejemplares similares
-
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011) -
The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report
por: Popescu, V, et al.
Publicado: (2015) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
por: Freiberg, Florentina Joyce, et al.
Publicado: (2013) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014) -
Subconjunctival sustained-release dexamethasone implant as an adjunct to trabeculectomy for primary open angle glaucoma
por: Furino, Claudio, et al.
Publicado: (2016)